ABN AMRO Investment Solutions Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$60.3M |
| 2 |
Eli Lilly
LLY
|
+$57.7M |
| 3 |
Ferguson
FERG
|
+$44.8M |
| 4 |
Workday
WDAY
|
+$37.6M |
| 5 |
KLA
KLAC
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$53.2M |
| 2 |
Oracle
ORCL
|
+$52M |
| 3 |
NVIDIA
NVDA
|
+$43.5M |
| 4 |
CME Group
CME
|
+$32M |
| 5 |
Mondelez International
MDLZ
|
+$31.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.59% |
| 2 | Financials | 14.34% |
| 3 | Consumer Discretionary | 12.29% |
| 4 | Healthcare | 11.45% |
| 5 | Industrials | 10.61% |
Similar funds
ABN AMRO Investment Solutions's Q4 2024 Portfolio in Review
As of Q4 2024, ABN AMRO Investment Solutions held 502 positions worth $5.36B, down 6.4% from $5.73B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
ABN AMRO Investment Solutions withdrew a net $352M in Q4 2024, closing 60 positions and reducing 253 holdings. Its most notable exit was BorgWarner, an estimated $13.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, ABN AMRO Investment Solutions opened a new position in Huazhu Hotels Group worth $3.51M.
- ABN AMRO Investment Solutions's largest Q4 2024 buy was Huazhu Hotels Group: 106,129 shares worth $3.51M.
- ABN AMRO Investment Solutions added most to Vertex Pharmaceuticals in Q4 2024, an estimated $60.3M increase.
- ABN AMRO Investment Solutions's biggest Q4 2024 reduction was Salesforce, cutting an estimated $53.2M.
- ABN AMRO Investment Solutions fully exited BorgWarner in Q4 2024, selling an estimated $13.7M.
- ABN AMRO Investment Solutions's ten largest holdings make up 31% of its $5.36B portfolio in Q4 2024.
- ABN AMRO Investment Solutions opened 18 new positions and closed 60 in Q4 2024.
- ABN AMRO Investment Solutions's portfolio value fell 6.4% quarter-over-quarter to $5.36B.
Based on ABN AMRO Investment Solutions's 13F filing for Q4 2024, filed 4 Sep 2025.